Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study

BACKGROUND: Evidence on the economic impact of chronic obstructive pulmonary disease (COPD) for third-party payers and society based on large real world datasets are still scarce. Therefore, the aim of this study was to estimate the economic impact of COPD severity and its comorbidities, stratified...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirsch, Florian, Schramm, Anja, Schwarzkopf, Larissa, Lutter, Johanna I., Szentes, Boglárka, Huber, Manuel, Leidl, Reiner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785905/
https://www.ncbi.nlm.nih.gov/pubmed/31601216
http://dx.doi.org/10.1186/s12931-019-1179-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785905/
https://www.ncbi.nlm.nih.gov/pubmed/31601216
http://dx.doi.org/10.1186/s12931-019-1179-7

Ejemplares similares